Teva Pharmaceuticals will pay $420 million in a federal case
Teva's Benign Opioid Settlement Isn't in the Bag Yet - WSJ
New York could get $524M under opioid settlements with Teva
Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says | Ctech
Teva Proposes $5B Settlement for Thousands of Opioid Lawsuits | BioSpace
$4.25 Billion Opioid Settlement by Teva Pharmaceuticals
Drugmaker Teva reaches opioid settlements worth $4.3 billion involving multiple states | Health News Florida
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva agrees to $4.35B settlement to end opioid lawsuits - Top Class Actions
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Texas AG announces $225M opioid settlement with Teva Pharmaceutical Industries | kvue.com
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva settles with Oklahoma for $85 million in opioid case | The Times of Israel
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
$4.4 Billion Opioid Settlement Gives Teva Stock a Boost | Barron's
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Teva enters opioid settlement agreement with US state Rhode Island
Teva, Texas strike opioid settlement worth $225M | Business Insurance
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PTTVJLJBQNLRBHDEX576PT7LII.jpg "Teva expects to start paying U.S. opioid settlement in 2023 | Reuters")
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva shares surge after announcing global opioid settlement
